Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Brain and Behavior Drugs > Antiepileptic drugs > Flashcards

Antiepileptic drugs Flashcards

You may prefer our related Brainscape-certified flashcards:
The Brain flashcards
1
Q

What causes a seizure? What is a seizure?

A

1) Abnormal, excessive, hyper-synchronous discharge of population of cortical neurons.
2) Massive disruption of electrical communication between neurons in the brain.

This is promoted by:
A) Increased excitatory synaptic neurotransmission
B) Decreased inhibitory synaptic neurotransmission
C) Alterations in voltage-gated ion channels to favor depolarization.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the goals of antiepileptic drugs?

A

A) Decreased excitatory synaptic neurotransmission (decreased glutamate)
B) Increased inhibitory synaptic neurotransmission (increased GABA)
C) Alterations in voltage-gated ion channels to favor polarization (alterations in sodium and calcium channels).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Voltage-gated sodium channel binders

A

Carbamazepine, phenytoin, lamotrigine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Neuronal voltage-gated calcium channel binders

A

Ethosuximide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GABA agonists

A

Phenobarbital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Drugs with multiple mechanisms

A

Valproate (sodium and calcium channels, GABA); topiarmate (sodium channels, glutamate, GABA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Drugs with unknown mechanisms

A

Gabapentin, pregabalin, levetiracetam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Side effects of ALL antiepileptic drugs

A 
Dose-related sedation
Cognitive impairment
Dizziness
Potential for long-term bone demineralization
Teratogenicity
Stevens-Johnson syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Stevens-Johnson syndrome?

A

Stevens-Johnson syndrome begins with flu-like symptoms, followed by a painful red or purplish rash that spreads and blisters. Then the top layer of the affected skin dies and sheds.

Stevens-Johnson syndrome is a medical emergency that usually requires hospitalization. Treatment focuses on eliminating the underlying cause, controlling symptoms and minimizing complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Side effects of many antiepileptic drugs (but not all)?

A

Bone marrow suppression and hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Carbamazepine: MOA

A

Binds to VG Na channels extending the inactivated phase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phenytoin: MOA

A

Binds VG Na channels, prolongs inactivated phase, but also affects resting membrane potential, synaptic transmission, second messenger systems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lamotrigine: MOA

A

Not understood. Binds to and inactivates neuronal VG Na channels. May selectively influence neurons that synthesize excitatory nts such as glutamate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Carbamazepine: Indications

A

Epilepsy, trigeminal neuralgia, mood stabilization in Type I bipolar disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Carbamazepine: Side effects

A

Decreased consciousness, N/V, double vision, ataxia.
Leukopenia (anemia and pancytopenia).
Hyponatremia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neuronal voltage-gated sodium channel binders.

A

Metabolized

in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which drugs are p450 inducers?

A

Carbamazepine and phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which drug does not affect p450 BUT is influenced by p450 inducers/inhibitors?

A

Lamotrigine

Note: Most important interactions are with estrogens (OCPs and ERT) and with other AEDS because of their affects on p450 system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Phenytoin: Indication

A

Epilepsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Phenytoin: Side Effects

A 
At toxic levels – decreased
consciousness, N/V, double
vision, ataxia.
PHT infamous for LT bone
demineralization. Specific to PHT –
gingival hyperplasia. IV PHT
associated with significant
hypotension, cardiac arrhythmias,
venous irritation and tissue
necrosis (fosphenytoin used
instead when IV indicated to reduce
these problems).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lamotrigine: Indications

A

Epilepsy, mood
stabilization in
bipolar disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Lamotrigine: Side effects

A 
At toxic levels – dizziness,
somnolence.
LTG is especially famous for terrible
problems with life-threatening
rash, initially occurring in up to 10%.
This risk has been attenuated by
very slow dosage titration. This
slow titration is especially
important when LTG is
administered with VPA, which is a
liver enzyme inhibitor. VPA
increases the plasma concentration
of LTG and thus increases the risk
of life-threatening rash. Unlike many
AEDs, bone marrow suppression
and hepatotoxicity are uncommon.
Specific to LTG – antidepressant
effect.
23
Q

Ethosuximide: MOA

A 
It affects the alpha
subunit of neuronal
voltage-gated calcium
channels heavily
expressed in some
thalamic neuron
populations (T-type
calcium channels).
24
Q

Ethosuximide: Indications

A

It is the first-line
agent in
absence
epilepsy.

25
Q

Phenobarbital: MOA

A 
Phenobarbital binds to
the GABA receptor,
augmenting the effect of
GABA by extending the
duration of GABA-mediated
chloride
channel openings. The
net effect is neuronal
hyperpolarization.
26
Q

Phenobarbital: Indications

A 
Epilepsy,
tremor (a closely
related
compound called
primidone is still
used for
treatment of
essential tremor)
27
Q

Phenobarbital: Side Effects

A 
At toxic levels – decreased
consciousness, nausea/vomiting,
double vision, ataxia.
Dose-related sedation and
cognitive impairment are
especially severe with phenobarbital
and greatly limits its use except in
status epilepticus, neonatal
seizures, and refractory epilepsies.
Specific to PBT – hyperactivity,
addiction.
28
Q

Phenobarbital: Metabolism

A

Metabolized in liver

29
Q

Phenobarbital: Drug Interactions

A

p450 inducer

30
Q

Valproate: MOA

A 
VPA blocks VG
sodium channels
(but at a site
different from that of
phenytoin and
carbamazepine),
increases brain
GABA
concentrations by
an unknown
mechanism, and
acts against T-type
calcium channels.
31
Q

Valproate: Indications

A 
Epilepsy,
mood
stabilization
in bipolar
disorder,
migraine
prophylaxis
32
Q

Valproate: Side Effects

A 
At toxic levels – decreased consciousness,
nausea/vomiting, ataxia.
Nausea/vomiting especially awful in the
uncoated form [brand Depakene], thus
usually given in a coated form [brand
Depakote]. Teratogenicity (while all AEDs
pose some increased risk of fetal
malformation, the risk is highest for VPA;
specifically associated with neural tube
defects, the incidence of which can be
reduced by folate supplementation).
Bone marrow suppression
(thrombocytopenia is most common, anemia
and pancytopenia also occur); hepatotoxicity
(VPA rarely used in children under 10).
Specific to VPA – low-amplitude, highfrequency
tremor, weight gain, hair
thinning (all common); pancreatitis
(infrequent). Rarely can cause
hyperammonemia with nml LFTs, leading to
lethargy, increased seizures, or death.
33
Q

Valproate: Metabolism

A

Metabolized in liver

34
Q

Valproate: Drug Interactions

A

p450 inhibitor

35
Q

Topiramate: MOA

A 
TPM blocks VG
sodium channels,
enhances the action
of GABA at a nonbenzodiazepine
site
on GABA-alpha, and
antagonizes the
NMDA glutamate
receptor.
36
Q

Topiramate: Indications

A

Epilepsy,
migraine
prophylaxis

37
Q

Topiramate: Side Effects

A

Cognitive impairment is a common complaint
with TPM when compared to the other second-generation
AEDs. Unlike many AEDs, bone
marrow suppression and hepatotoxicity are
very uncommon. Specific to TPM – weight
loss, increased risk of kidney stones,
decreased sweating, paresthesias, mood
disturbances, metabolic acidosis (rare).

38
Q

Topiramate: Metabolism

A 
70%
excreted
unchanged
by the
kidney, 30%
metabolized
in the liver
39
Q

Gabapentin: MOA

A 
Binds to auxiliary
alpha-2-delta
subunit of a
neuronal VG
calcium channel,
which may inhibit
inward Ca currents
and stop NT release.
40
Q

Gabapentin: Indications

A 
Epilepsy, chronic pain,
neuropathic
pain (not FDA
approved for
this but is
frequently
used off-label).
41
Q

Gabapentin: Side Effects

A

At toxic levels – decreased consciousness,
ataxia. Unlike many AEDs, not associated with
hepatotoxicity or bone marrow suppression.
Specific to GBP – peripheral edema and
weight gain.

42
Q

Gabapentin: Metabolism

A 
100%
excreted
unchanged
in the urine
(requires
dose
adjustment
for kidney dz).
43
Q

Gabapentin: Drug Interactions

A

Must be taken at least two hours after use of antacids (which impair bioavailability)

44
Q

Pregabalin: MOA

A 
Binds to auxiliary
alpha-2-delta
subunit of a
neuronal voltagedependent
calcium
channel.
45
Q

Pregabalin: Indications

A

Epilepsy,
neuropathic
pain,
fibromyalgia.

46
Q

Pregabalin: Side Effects

A

At toxic levels – decreased consciousness,
ataxia. Unlike many AEDs, not associated with
hepatotoxicity or bone marrow suppression.
Specific to PGB – peripheral edema and
weight gain.

47
Q

Which drugs are secreted 100% unchanged in urine?

A

Gabapentin, pregabalin, levetiracetam (drugs with unknown mechanisms).

48
Q

Pregabalin: Side Effects

A 
Must be taken at
least two hours
after the use of
antacids (which
impair its
bioavailability)
49
Q

Levetiracetam: MOA

A 
Not well-understood;
available data show
that it binds to
SV2A, a protein in
pre-synaptic
neurotransmitter
vesicles, and likely
modulates
neuronal calcium
channels
50
Q

Levetiracetam: Indications

A

Epilepsy

51
Q

Levetiracetam: Side Effects

A

Unlike many AEDs, not associated with
hepatotoxicity or bone marrow suppression
LEV has very few serious side effects.
Irritability/other significant psychiatric problems
can occur in 10-15% of patients

52
Q

Levetiracetam: Drug Interactions

A

No significant drug interactions!

53
Q

Levetiracetam is an attractive AED because?

A

Very few pharmacokinetic interactions with other drugs (like other AEDs or OCPs).

Can be used in patients with hepatic failure because it’s excreted 100% renally.

LEV does not require a titration period, and it appears to have a very rapid onset of action.

  • The drug is relatively well tolerated and effective (74% of people are still taking it at one year).
  • An intravenous formulation of LEV has been approved for use in clinical situations when patients are temporarily unable to take oral medication.
  • An extended-release formulation of LEV is available (once-a-day dosing of AEDs is associated with increased compliance).

Brain and Behavior Drugs (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions